Cleared Traditional

K180202 - Histofluor Rodent LKS Fluorescent Antib...

K180202 is an FDA 510(k) clearance for Histofluor Rodent LKS Fluorescent Antib..., manufactured by Immuno Concepts, N.A. , Ltd.. The device is a Class 2 Immunology device with product code DBL cleared through the Traditional 510(k) pathway after a 268-day FDA review.

K180202 · Immuno Concepts, N.A. , Ltd. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2018
Decision
268d
Days
Class 2
Risk

K180202 is an FDA 510(k) clearance for the Histofluor Rodent LKS Fluorescent Antibody Test System, Image Navigator by Im.... Classified as Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control (product code DBL), Class II - Special Controls.

Submitted by Immuno Concepts, N.A. , Ltd. (Sacramento, US). The FDA issued a Cleared decision on October 19, 2018 after a review of 268 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Immuno Concepts, N.A. , Ltd. devices

FDA 510(k) Submission Details - K180202

510(k) Number K180202 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 24, 2018
Decision Date October 19, 2018
Days to Decision 268 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
164d slower than avg
Panel avg: 104d · This submission: 268d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DBL Device Classification - Class 2, Special Controls

Product Code DBL Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DBL Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control

All 12
Devices cleared under the same product code (DBL) and FDA review panel - the closest regulatory comparables to K180202.
NOVA LITE ENDOMYSIAL
K980312 · Inova Diagnostics, Inc. · Apr 1998
DIASTAT ANTI-GLOMERULAR BASEMENT MEMBRANE KIT
K963525 · Shield Diagnostics, Ltd. · Nov 1996
RIT LIVER, KIDNEY, STOMACH IFA KIT
K955431 · The Binding Site, Ltd. · Apr 1996
ANTI-RETICULIN ANTIBODY (ARA) TEST
K913360 · Immco Diagnostics, Inc. · Sep 1994
ANTI-ENDOMYSIAL ANTIBODY TEST
K912551 · Immco Diagnostics, Inc. · Jun 1993
MEDICA IIF ANTI-SKIN ANTIBODY TEST KIT
K902237 · Medica Corp. · Jul 1990